# Probiotic Supplementation During Pregnancy in Preeclampsia High-risk Groups

> **NCT05554185** · NA · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 338 (estimated)

## Conditions studied

- PE (Pre-eclampsia) High-risk Population With Gut Microbiota Dysbiosis During Their Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** aspirin 100mg and probiotics 1 bag

## Key facts

- **NCT ID:** NCT05554185
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-21
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 338 (ESTIMATED)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05554185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05554185, "Probiotic Supplementation During Pregnancy in Preeclampsia High-risk Groups". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05554185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*